Yon-Z
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Yon-Z
Yon-Z is recorded as Analyst at H.C. Wainwright. Yon-Z has spoken on 1 investor event across 1 company, most recently for Entrada Therapeutics, Inc. on May 7, 2026. The companies whose calls Yon-Z spoke on are classified in the Healthcare sector.
Yon-Z on recent calls
“So, my first question relates to ENTR801. What remaining IND-enabling work and regulatory interactions need to be completed before clinical entry? And should first human dosing be viewed as a possible 26 then, or something that's more likely as a 27 once?”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current